Home
>
National Drug Code (NDC)
>
VIDAZA
VIDAZA - 59572-102-01 - (azacitidine)
Drug Information of VIDAZA
| Product NDC: | 59572-102 |
| Proprietary Name: | VIDAZA |
| Non Proprietary Name: | azacitidine |
| Active Ingredient(s): | 100 mg/1 & nbsp; azacitidine |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VIDAZA
| Product NDC: | 59572-102 |
| Labeler Name: | Celgene Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050794 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040705 |
Package Information of VIDAZA
| Package NDC: | 59572-102-01 |
| Package Description: | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (59572-102-01) |
NDC Information of VIDAZA
| NDC Code | 59572-102-01 |
| Proprietary Name | VIDAZA |
| Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (59572-102-01) |
| Product NDC | 59572-102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | azacitidine |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20040705 |
| Marketing Category Name | NDA |
| Labeler Name | Celgene Corporation |
| Substance Name | AZACITIDINE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
